Ikarian Capital, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Traws Pharma, Inc. Common stock, par value $.01 per share
Symbol: TRAW
Shares outstanding: 8,133,373 shares
Disclosed Ownership: 812,524 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 17:11:54 UTC
Date of event: 31 Dec 2025
Previous filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	10%	812,524	0	812,524	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	10%	812,524	0	812,524	/s/ Neil Shahrestani	Neil Shahrestani